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In order to conquer cancers, various attempts have been
made; early detection, surgery, irradiation, and chemotherapy
using more than 100 anticancer agents and combinations
thereof. In spite of these endeavors, the 5-yr survival rate still
lingered around 40% in the late 1970s. At that time, a few
Korean scientists knowing such limitation in cancer treat-
ment came to the conclusion that the only way to get the
load off cancers counts on the primary prevention by means
of non-toxic natural products. And thus, they tried to find a
non-toxic chemopreventives from dietary components, phyto-
chemicals, and medicinal plants as a source for chemopreven-
tives. After more than two decades since then, chemopreven-
tion has become a most promising strategy to reduce cancer
risk.
Insam (ginseng) has already been used for more than two
thousand years since this plant was known to make our body
energetic and keep stamina up, and extend longevity. For the
last two decades, this action of Insam learned from experi-
ence have driven many scientists to study its chemopreven-
tive effects, using different disciplines such as experimental
anticarcinogenesis, epidemiology, biochemistry, molecular
biology, and clinical medicine. Due to these efforts, much
knowledge on this action of Insam has been accumulated.
Now, it is time to review the accumulated knowledge. For-
tunately, we held a very timely meeting on April 20, 2001
in Seoul that was the International Symposium on Cancer
Prevention of Insam. Luckily, the articles presented in this
meeting were published as Supplement December, 2001 of
Journal of Korean Medical Science. 
The Supplement contains Brief Introduction of Insam, Ex-
perimental and Epidemiological Basis of Cancer Prevention
of Insam, Biochemistry of Insam Saponins, Molecular Mech-
anism of Action of Insam, and Chemopreventive Effects on
Various Organs.
We would like to thank from the bottom of our heart, the
speakers who presented outstanding articles in the sympo-
sium, Professor Je G. Chi, President of the Korean Acade-
my of Medical Sciences, Prof. Jung-Gi Im, Co-chairman,
and other members of the Organizing Committee, and the
companies and industries who supported the successful
accomplishment of the symposium. 
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